Company Filing History:
Years Active: 2008
Title: Jan Kelder: Innovator in Fertility Therapies
Introduction
Jan Kelder is a notable inventor based in BH Oss, Netherlands. He has made significant contributions to the field of fertility regulation through his innovative work. His research focuses on developing compounds that can activate specific receptors related to fertility.
Latest Patents
Jan Kelder holds a patent for "Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity." This invention involves glycine-substituted thieno[2,3-d]pyrimidine derivatives, which possess both LH and FSH receptor activating activity. These compounds can be utilized in fertility regulating therapies, offering new possibilities for treatment.
Career Highlights
Jan Kelder is associated with N.V. Organon, a company known for its focus on pharmaceutical innovations. His work at Organon has allowed him to contribute to advancements in reproductive health and fertility treatments.
Collaborations
Jan has collaborated with notable colleagues, including Robert Gerardus Jules Marie Hanssen and Cornelis Marius Timmers. These partnerships have enhanced the research and development of fertility-related therapies.
Conclusion
Jan Kelder's innovative work in the field of fertility regulation highlights the importance of scientific research in improving health outcomes. His contributions through patents and collaborations continue to pave the way for advancements in reproductive therapies.